CIBC analyst John Zamparo reiterated a Hold rating on Aurora Cannabis (ACB) yesterday and set a price target of C$2.25. The company’s shares closed last Monday at $1.47, close to its 52-week low of $1.43.
According to TipRanks.com, Zamparo is ranked #5603 out of 5913 analysts.
Aurora Cannabis has an analyst consensus of Hold, with a price target consensus of $2.34, a 63.6% upside from current levels. In a report released today, MKM Partners also upgraded the stock to Hold with a C$1.75 price target.
See today’s analyst top recommended stocks >>
Based on Aurora Cannabis’ latest earnings release for the quarter ending December 31, the company reported a quarterly GAAP net loss of $974 million. In comparison, last year the company had a GAAP net loss of $180 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Aurora Cannabis, Inc. engages in the production, distribution and sale of cannabis products. It also produces and sells indoor cultivation systems and hemp related food products. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.
Read More on ACB:
- The Fate of Aurora Cannabis (ACB) Stock Remains Up in the Air
- Aurora Cannabis (ACB): With CEO Stepping Down, All Eyes Are on Nelson Peltz
- Aurora Cannabis (ACB): Key Growth Catalysts to Look for
- Aurora Cannabis (ACB): Fade the Bulk Wholesale Induced Rally
- Piper Sandler Plays a Dirge for Aurora Cannabis (ACB) Stock